人工内耳の世界市場：患者タイプ・エンドユーザー・地域別の分析・予測 (2024-2034年)

世界の人工内耳の市場規模は、2023年の24億2,440万米ドルから、予測期間中は9.02%のCAGRで推移し、2034年には66億3,990万米ドルに急増すると予測されています。

人工内耳の市場は近年堅調な伸びを示しており、今後も拡大が続く見通しですが、そのペースは状況によって変化する可能性があります。人工内耳は、従来の補聴器では効果が得られない中等度から重度の難聴者に音の知覚を提供するために設計された電子医療機器です。これらのインプラントは、内耳（蝸牛）の損傷部分をバイパスして聴神経を直接刺激するため、ユーザーは音を知覚できるようになり、会話の理解度が向上します。

人工内耳の世界市場は、聴力回復技術の進歩や感音性難聴の有病率の増加に後押しされ、大きな成長を遂げています。世界保健機関（WHO）が発表したデータによると、世界中で4億3,000万人以上が難聴に苦しんでおり、この数は2050年までに7億人に達すると予想されています。さらに、より効果的でユーザーフレンドリーなAIベースの音声処理、ワイヤレス接続、MRI対応インプラントなど、人工内耳技術の進歩により、患者の予後が大幅に改善される見通しです。世界の政府や医療機関も、好意的な償還政策や資金提供イニシアティブを通じて市場を支援しており、小児患者と成人患者の両方にとってのアクセシビリティを高めています。

患者タイプ別では、成人セグメントが市場で優位に：

患者タイプ別では、成人セグメントが2023年に最大のシェアを占め、予測期間中はCAGR 8.55%で推移し、2034年には42億8,270万米ドルに達すると予測されています。加齢に伴う難聴の有病率が上昇し、中度から重度の難聴に対する効果的な治療法として人工内耳の認知度が高まっています。特に北米や欧州などの先進地域では、世界の高齢者人口の増加に伴い、成人の人工内耳に対する需要が大幅に増加しています。さらに、インプラントの設計、手術技術、インプラント後のリハビリテーションにおける技術革新が続いていることからも、成人のセグメントは今後数年間、人工内耳市場における優位性を維持すると予想されています。

エンドユーザー別では、病院セグメントが市場で優位に：

エンドユーザー別では、病院セグメントが2023年に最大のシェアを占め、予測期間中はCAGR 8.71％で推移し、2034年には41億8,310万米ドルに達すると予測されています。同市場が優位に立つ主な要因は、高度な手術インフラ、耳鼻咽喉科用機器、熟練した医療専門家、移植を成功させるために必要な術後リハビリテーションサービスが利用可能である点にあります。病院は、小児患者と成人患者に対して、包括的な診断評価、外科的移植、長期的な聴覚サポートを提供する主要なケアポイントとして機能しています。耳鼻咽喉科専門医、聴覚士、言語療法士、リハビリテーション専門家を含む集学的チームが存在することで、患者の最適な転帰が保証され、病院での人工内耳埋込み手術がさらに好まれる要因となっています。

人工内耳市場の分類

セグメンテーション1：患者タイプ別

• 成人
• 小児

セグメンテーション2：エンドユーザー別

• 病院
• 耳鼻咽喉科クリニック
• その他

セグメンテーション3：地域別

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他
• アジア太平洋
  • 日本
  • 中国
  • インド
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ

当レポートでは、世界の人工内耳の市場を調査し、主要動向、市場影響因子の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

エグゼクティブサマリー

範囲と定義

第1章 市場：業界の展望

• 動向：現在および将来の影響評価
• サプライチェーン分析
• 規制状況
• 市場力学の概要
  • 影響分析
  • 市場促進要因
  • 市場抑制要因
  • 市場機会

第2章 世界の人工内耳市場：患者タイプ別

• 成人
• 小児

第3章 世界の人工内耳市場：エンドユーザー別

• 病院
• 耳鼻咽喉科クリニック
• その他

第4章 地域

• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第5章 市場：競合ベンチマーキング・企業プロファイル

• 主な展開
• 企業プロファイル
  • iotaMotion, Inc.
  • Envoy Medical
  • Amplifon, (GAES)
  • Cochlear Ltd.
  • Sonova Holdings AG
  • MED-EL Medical Electronics
  • ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD. (Nurotron)

第6章 調査手法

List of Figures

• Figure 1: Global Cochlear Implants Market (by Patient Type), $Million, 2023 and 2034
• Figure 2: Global Cochlear Implants Market (by End User), $Million, 2023 and 2034
• Figure 3: Global Cochlear Implant Market (by Region), $Million, 2023, 2027, and 2034
• Figure 4: Key Events to Keep Track of in the Global Cochlear Implants Market
• Figure 5: Supply Chain Analysis: Global Cochlear Implants Market
• Figure 6: Impact Analysis of Cochlear Implants Market Navigating Factors, 2024-2034
• Figure 7: North America Cochlear Implants Market, $Million, 2023-2034
• Figure 8: U.S. Cochlear Implants Market, $Million, 2023-2034
• Figure 9: Canada Cochlear Implants Market, $Million, 2023-2034
• Figure 10: Europe Cochlear Implants Market, $Million, 2023-2034
• Figure 11: Germany Cochlear Implants Market, $Million, 2023-2034
• Figure 12: U.K. Cochlear Implants Market, $Million, 2023-2034
• Figure 13: France Cochlear Implants Market, $Million, 2023-2034
• Figure 14: Italy Cochlear Implant Market, $Million, 2023-2034
• Figure 15: Spain Cochlear Implants Market, $Million, 2023-2034
• Figure 16: Rest-of-Europe Cochlear Implants Market, $Million, 2023-2034
• Figure 17: Asia-Pacific Cochlear Implants Market, $Million, 2023-2034
• Figure 18: Japan Cochlear Implants Market, $Million, 2023-2034
• Figure 19: China Cochlear Implants Market, $Million, 2023-2034
• Figure 20: India Cochlear Implants Market, $Million, 2023-2034
• Figure 21: Rest-of-Asia-Pacific Cochlear Implants Market, $Million, 2023-2034
• Figure 22: Latin America Cochlear Implants Market, $Million, 2023-2034
• Figure 23: Brazil Cochlear Implants Market, $Million, 2023-2034
• Figure 24: Mexico Cochlear Implants Market, $Million, 2023-2034
• Figure 25: Rest-of-Latin America Cochlear Implants Market, $Million, 2023-2034
• Figure 26: Middle East and Africa Cochlear Implants Market, $Million, 2023-2034
• Figure 27: Strategic Initiatives, January 2020-January 2025
• Figure 28: Data Triangulation
• Figure 29: Top-Down and Bottom-Up Approach
• Figure 30: Assumptions and Limitations

List of Tables

• Table 1: Key Trends, Global Cochlear Implants Market
• Table 2: Evolution of Component Size in Hearing Implants
• Table 3: Global Prevalence of Hearing Loss, 2019-2021
• Table 4: Global Cochlear Implants Market (by Patient Type), $Million, 2023-2034
• Table 5: Global Cochlear Implants Market (by End User), $Million, 2023-2034
• Table 6: Global Cochlear Implants Market (by Region), $Million, 2023-2034
• Table 7: Recent Developments by Companies in the Global Cochlear Implants Market, 2023 and 2024

Introduction of Cochlear Implants

The global cochlear implants market, initially valued at $2,424.4 million in 2023, is set to witness substantial growth, projected to surge to $6,639.9 million by 2034, marking a remarkable compound annual growth rate (CAGR) of 9.02% over the period from 2024 to 2034. The cochlear implants market has shown robust growth in recent years and is poised to continue expanding, though the pace may vary under different conditions. Cochlear implants are electronic medical devices designed to provide sound perception to individuals with severe-to-profound hearing loss who do not benefit from conventional hearing aids. These implants directly stimulate the auditory nerve, bypassing damaged parts of the inner ear (cochlea), enabling users to perceive sound and improve speech comprehension.

Market Introduction

The global cochlear implants market has been experiencing significant growth, fueled by advancements in hearing restoration technologies and the increasing prevalence of sensorineural hearing loss. According to the data published by the World Health Organization (WHO), over 430 million people worldwide suffer from disabling hearing loss, with this number expected to reach 700 million by 2050. Additionally, advancements in cochlear implant technology, such as AI-based sound processing, wireless connectivity, and MRI-compatible implants, have significantly improved patient outcomes, making these devices more effective and user-friendly. Governments and healthcare organizations worldwide are also supporting the market through favorable reimbursement policies and funding initiatives, increasing accessibility for both pediatric and adult patients.

Industrial Impact

The cochlear implants market has significantly influenced the healthcare landscape, driven by key players such as Cochlear Limited., Sonova Holdings AG, Amplifon, (GAES), and others. These companies have been at the forefront, providing cutting-edge products for cochlear implants.

Moreover, the market has been further shaped by strategic collaborations, mergers, and R&D investments, which enable companies to expand their global presence and introduce innovative solutions. With the increasing focus on understanding tissue architecture and disease mechanisms, the competitive landscape of the cochlear implants market is dynamic, with innovation and customer-centric approaches driving differentiation and growth.

Market Segmentation for Cochlear Implants Market:

Segmentation 1: by Patient Type

• Adult
• Pediatric

Adult Segment to Dominate the Cochlear Implants Market (by Patient Type)

Based on patient type, the global cochlear implants market was led by the adult segment, which accounted for the largest share in 2023 and is expected to reach $4,282.7 million by 2034, registering a CAGR of 8.55% during the forecast period 2024-2034. The rising prevalence of age-related hearing loss and increasing awareness of cochlear implantation as an effective treatment for severe-to-profound hearing impairment. With a growing global geriatric population, particularly in developed regions such as North America and Europe, the demand for cochlear implants among adults is increasing significantly. Additionally, with continued innovation in implant design, surgical techniques, and post-implantation rehabilitation, the adult segment is expected to maintain its dominance in the cochlear implant market in the coming years.

Segmentation 2: by End User

• Hospitals
• ENT Clinics
• Others

Hospitals Segment to Dominate the Cochlear Implants Market (by End User)

Based on end user, hospitals accounted for the largest share in 2023 and are expected to reach $4,183.1 million by 2034, registering a CAGR of 8.71% during the forecast period 2024-2034. A key factor contributing to the market's dominance is the availability of advanced surgical infrastructure, ENT devices, skilled healthcare professionals, and post-operative rehabilitation services required for successful implantation. Hospitals serve as the primary point of care for both pediatric and adult patients, offering comprehensive diagnostic assessments, surgical implantation, and long-term audiological support. The presence of multidisciplinary teams, including ENT specialists, audiologists, speech therapists, and rehabilitation experts, ensures optimal patient outcomes, further driving preference for hospital-based cochlear implant procedures.

Segmentation 3: by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Rest-of-Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest-of-Latin America
• Middle East and Africa

In 2023, North America region dominated the global cochlear implants market; however, the Asia-Pacific region is expected to register the highest CAGR of 10.53% during the forecast period 2024-2034. high healthcare expenditure, advanced medical infrastructure, and strong government support for hearing loss treatment are a few factors driving the growth of the region. The increasing awareness about hearing restoration solutions, along with the rising adoption of bilateral cochlear implantation, further supports market growth. Moreover, an aging population and the rising prevalence of age-related hearing loss have fueled demand among older adults seeking cochlear implants to improve their quality of life.

Recent Developments in the Cochlear Implants Market

• In May 2024, Cochlear Limited completed the acquisition of Oticon Medical's cochlear implant business from Demant, integrating approximately 20,000 Oticon Medical cochlear implant customers into its operations. This strategic move aims to provide continued support and transition these customers to Cochlear's technology platform over time.
• In March 2023, MED-EL Medical Electronics introduced direct streaming for their cochlear implant patients. This feature, available in their new MED-EL cochlear implant systems, allows users to stream audio directly from compatible devices (such as smartphones) to their implants, improving sound quality and convenience. This innovation enhances accessibility and user experience for individuals with hearing loss.
• In November 2024, Cochlear Limited launched the Nucleus 8 Sound Processor, featuring enhanced connectivity for direct streaming from Apple and Android devices and improved hearing in noisy environments. This innovation aims to provide clearer sound and greater convenience for individuals with hearing loss.

Demand - Drivers, Challenges, and Opportunities

Market Drivers:

Rising Prevalence of Hearing Loss: The global prevalence of hearing loss is increasing at an alarming rate, driven by factors such as aging populations, excessive noise exposure, genetic predisposition, and untreated ear infections. According to the World Health Organization (WHO), over 1.5 million people worldwide currently experience some degree of hearing impairment, with this number expected to rise due to demographic and environmental factors. Additionally, increased awareness and early diagnosis are leading to a higher adoption of hearing aids and cochlear implants, addressing the needs of individuals with severe to profound hearing loss.

Market Challenges:

High Cost of Devices and Surgery: Despite the benefits of cochlear implants, their high cost remains a significant barrier limiting market penetration, particularly in low- and middle-income countries. A single cochlear implant procedure (including the device, surgery, and rehabilitation therapy) can cost $50,000 to $100,000 in the U.S., and prices are similarly steep elsewhere. Without insurance or subsidies, this expense is prohibitive for most patients. In developing regions, the lack of affordability is a primary reason that so few people who need implants receive them. Globally, it's estimated that only about 5-10% of candidates who could benefit from a cochlear implant have one, largely due to cost and access issues. The result is a substantial unmet medical need, where millions continue to live with severe hearing loss because the up-front price of treatment is out of reach.

Market Opportunities:

Increasing Adoption in Emerging Markets: Emerging markets present a significant growth opportunity for the cochlear implants market due to improving healthcare infrastructure, rising awareness of hearing loss treatments, and increasing disposable income. Countries in Asia-Pacific, Latin America, and Africa are witnessing a surge in demand for cochlear implants as governments and healthcare organizations work toward expanding access to advanced medical technologies. Additionally, initiatives like subsidized healthcare programs, insurance coverage expansion, and partnerships with global medical device companies are making cochlear implants more affordable and accessible.

How can this report add value to an organization?

Product/Innovation Strategy: The global cochlear implants market has been extensively segmented based on various categories, such as patient type, end user, and region.

Growth/Marketing Strategy: Mergers, acquisitions, and product launches accounted for the maximum number of key developments in the market.

Competitive Strategy: The global cochlear implants market has numerous established players with product portfolios. Key players in the global cochlear implants market analyzed and profiled involve established players offering products for cochlear implants.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

• The base year considered for the calculation of the market size is 2023. A historical year analysis has been done for the period FY2021-FY2022. The market size has been estimated for FY2023 and projected for the period FY2024-FY2034.
• The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of upstream and downstream products of the cochlear implants market.
• The market size was estimated and validated using both bottom-up and top-down analyses. The market size for each type, patient type, and end user was estimated for the bottom-up approach. These were further added to cumulate the market size of the global cochlear implants market.
• The top-down analysis was conducted to arrive at the market contributions of various segments as defined in the scope.
• The base currency considered for the market analysis is US$. Currencies other than the US$ have been converted to the US$ for all statistical calculations, considering the average conversion rate for that particular year.
• The market has been mapped based on available cochlear implants. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in cochlear implants, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

• validation and triangulation of all the numbers and graphs
• validation of the report's segmentation and key qualitative findings
• understanding the competitive landscape and business model
• current and proposed production values of a product by market players
• validation of the numbers of the different segments of the market in focus
• percentage split of individual markets for regional analysis

Secondary Research

Open Sources

• Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
• Annual reports, SEC filings, and investor presentations of the leading market players
• Company websites and detailed study of their product portfolio
• Gold standard magazines, journals, white papers, press releases, and news articles
• Paid databases

The key data points taken from the secondary sources include:

• segmentations and percentage shares
• data for market value
• key industry trends of the top players of the market
• qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
• quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts, who have analyzed company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Cochlear Limited.
• Sonova Holding AG.
• Zhejiang Nurotron Biotechnology Co., Ltd. (Nurotron)
• MED-EL Medical Electronics

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Miniaturization of Sensors and Components in Hearing Implants
• 1.2 Supply Chain Analysis
• 1.3 Regulatory Landscape
  • 1.3.1 U.S.
  • 1.3.2 Europe
  • 1.3.3 Asia-Pacific
  • 1.3.4 Rest-of-the-World
• 1.4 Market Dynamics Overview
  • 1.4.1 Impact Analysis
  • 1.4.2 Market Drivers
    • 1.4.2.1 Rising Prevalence of Hearing Loss
    • 1.4.2.2 Technological Advancements in Cochlear Implants
    • 1.4.2.3 Government Health Initiatives and Favorable Reimbursement
  • 1.4.3 Market Restraints
    • 1.4.3.1 High Cost of Devices and Surgery
    • 1.4.3.2 Low Awareness Related to Cochlear Implants
  • 1.4.4 Market Opportunities
    • 1.4.4.1 Increasing Adoption in Emerging Markets

2 Global Cochlear Implants Market, by Patient Type

• 2.1 Adults
• 2.2 Pediatric

3 Global Cochlear Implants Market, by End User

• 3.1 Hospitals
• 3.2 ENT Clinics
• 3.3 Others

4 Regions

• 4.1 North America
  • 4.1.1 Regional Overview
  • 4.1.2 Driving Factors for Market Growth
  • 4.1.3 Factors Challenging the Market
  • 4.1.4 Market Sizing and Forecast
    • 4.1.4.1 U.S.
    • 4.1.4.2 Canada
• 4.2 Europe
  • 4.2.1 Regional Overview
  • 4.2.2 Driving Factors for Market Growth
  • 4.2.3 Factors Challenging the Market
  • 4.2.4 Market Sizing and Forecast
    • 4.2.4.1 Germany
    • 4.2.4.2 U.K.
    • 4.2.4.3 France
    • 4.2.4.4 Italy
    • 4.2.4.5 Spain
    • 4.2.4.6 Rest-of-Europe
• 4.3 Asia-Pacific
  • 4.3.1 Regional Overview
  • 4.3.2 Driving Factors for Market Growth
  • 4.3.3 Factors Challenging the Market
  • 4.3.4 Market Sizing and Forecast
    • 4.3.4.1 Japan
    • 4.3.4.2 China
    • 4.3.4.3 India
    • 4.3.4.4 Rest-of-Asia-Pacific
• 4.4 Latin America
  • 4.4.1 Regional Overview
  • 4.4.2 Driving Factors for Market Growth
  • 4.4.3 Factors Challenging the Market
  • 4.4.4 Market Sizing and Forecast
    • 4.4.4.1 Brazil
    • 4.4.4.2 Mexico
    • 4.4.4.3 Rest-of-Latin America
• 4.5 Middle East and Africa
  • 4.5.1 Regional Overview
  • 4.5.2 Market Sizing and Forecast

5 Markets - Competitive Benchmarking & Company Profiles

• 5.1 Key Developments
  • 5.1.1 Key Strategies and Development
• 5.2 Company Profiles
  • 5.2.1 iotaMotion, Inc.
    • 5.2.1.1 Overview
    • 5.2.1.2 Top Products/Product Portfolio
    • 5.2.1.3 Top Competitors
    • 5.2.1.4 Target Customers
    • 5.2.1.5 Analyst View
  • 5.2.2 Envoy Medical
    • 5.2.2.1 Overview
    • 5.2.2.2 Top Products/Product Portfolio
    • 5.2.2.3 Top Competitors
    • 5.2.2.4 Target Customers
    • 5.2.2.5 Analyst View
  • 5.2.3 Amplifon, (GAES)
    • 5.2.3.1 Overview
    • 5.2.3.2 Top Products/Product Portfolio
    • 5.2.3.3 Top Competitors
    • 5.2.3.4 Target Customers
    • 5.2.3.5 Analyst View
  • 5.2.4 Cochlear Ltd.
    • 5.2.4.1 Overview
    • 5.2.4.2 Top Products/Product Portfolio
    • 5.2.4.3 Top Competitors
    • 5.2.4.4 Target Customers
    • 5.2.4.5 Analyst View
  • 5.2.5 Sonova Holdings AG
    • 5.2.5.1 Overview
    • 5.2.5.2 Top Products/Product Portfolio
    • 5.2.5.3 Top Competitors
    • 5.2.5.4 Target Customers
    • 5.2.5.5 Analyst View
  • 5.2.6 MED-EL Medical Electronics
    • 5.2.6.1 Overview
    • 5.2.6.2 Top Products/Product Portfolio
    • 5.2.6.3 Top Competitors
    • 5.2.6.4 Target Customers
    • 5.2.6.5 Analyst View
  • 5.2.7 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD. (Nurotron)
    • 5.2.7.1 Overview
    • 5.2.7.2 Top Products/Product Portfolio
    • 5.2.7.3 Top Competitors
    • 5.2.7.4 Target Customers
    • 5.2.7.5 Analyst View

6 Research Methodology

• 6.1 Data Sources
  • 6.1.1 Primary Data Sources
  • 6.1.2 Secondary Data Sources
  • 6.1.3 Data Triangulation
• 6.2 Market Estimation and Forecast